The Patent Finder

CB Therapeutics, Inc.

Also on record
Records under this name other than the patents CB Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to CB Therapeutics, Inc.

PatentTitleStatus Expires Confidence
US 9,359,338Cyclopropanecarboxamido-substitute aromatic compounds as anti-tumor agents
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,840,477Cyclopropanecarboxamido-substituted aromatic compounds as anti-tumor agents
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,695,175Highly selective c-Met inhibitors as anticancer agents
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,981,994Anti PD-1 antibodies
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,111,300Anti PD-L1 Antibodies
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,428,146Anti PD-1 antibodies
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,435,470ANTI-PD-L1 Antibodies
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,560,429Anti PD-1 antibodies
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,827,707Anti PD-L1 Antibodies
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,441,164Biosynthetic Production of Psilocybin and Related Intermediates in Recombinant Organisms
Lapsed on the fee record
Ended Sep 13, 2026 · High confidence
Lapsed on the fee recordEnded Sep 13, 2026High confidence
10 of 15 patents shown.
Pro members see all 15.
Pro members: see all 15 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited